AcuityAds Inc. Receives Approximately $200,000 Order from a Global Pharmaceutical Company

TORONTO, June 4, 2015 /CNW/ - AcuityAds Holdings Inc. (TSXV:AT) ("AcuityAds" or "Company"), a leading provider of targeted digital media solutions, enabling advertisers to connect intelligently with their audiences across online display, video, social and mobile campaigns, today announced that the Company has received an order for approximately $200,000 from a major global pharmaceutical company to deliver a strategic advertising campaign for a period of three months. 

"Pharmaceutical advertising is highly regulated and requires a best in class programmatic advertising platform to ensure effective targeting and delivery of digital media results," said Tal Hayek, CEO of AcuityAds. "The quality of our technology and its ability to continuously learn, optimize and deliver consistent results was the reason for winning the agreement with this highly reputable global company."

The healthcare and pharmaceutical industry represents one of six core vertical areas of focus for AcuityAds that, combined with publisher direct relationships and third party data source integrations, enables AcuityAds to deliver greater granularity in audience targeting. In addition to Healthcare, AcuityAds' other core verticals are Financial Services, Automotive, Retail, Politics, and Entertainment. 

About AcuityAds:
AcuityAds has developed a programmatic marketing platform powered by proprietary machine learning technology that allows advertisers to target and connect intelligently with their audiences across online display, video, social and mobile campaigns. With operations in New York, Toronto, Los Angeles, Montreal, Chicago, and Boston, AcuityAds's customers include both large Fortune 500 enterprises and small to mid-sized businesses. For more information, visit www.acuityads.com.

Disclaimer in regards to Forward-looking Statements

Certain statements included herein constitute "forward-looking statements" within the meaning of applicable securities laws, including but not limited to statements regarding AcuityAds' areas of focus and service offerings. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Investors are cautioned not to put undue reliance on forward-looking statements. Except as required by law, AcuityAds does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events. The Company's client that has been mentioned in this press release has the right to exercise an out clause right at any time during the advertising campaign.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE AcuityAds Inc.

Babak Pedram, Investor Relations, Virtus Advisory Group Inc., 416-644-5081, [email protected]; Tal Hayek, Chief Executive Officer, AcuityAds Inc., 416-218-9888, [email protected]